These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2984151)

  • 1. Fast neutrons and misonidazole for malignant astrocytomas.
    Kurup PD; Pajak TF; Hendrickson FR; Nelson JS; Mansell J; Cohen L; Awschalom M; Rosenberg I; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 1985 Apr; 11(4):679-86. PubMed ID: 2984151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group.
    Stadler B; Kärcher KH; Kogelnik HD; Szepesi T
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1713-7. PubMed ID: 6090368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.
    Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R
    Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Instant-mix" whole brain photon with neutron boost radiotherapy for malignant gliomas.
    Kolker JD; Halpern HJ; Krishnasamy S; Brown F; Dohrmann G; Ferguson L; Hekmatpanah J; Mullan J; Wollman R; Blough R
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):409-14. PubMed ID: 2168355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
    Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
    Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast neutron therapy for malignant astrocytomas. A review.
    Kurup PD; Pajak TF; Nelson JS; Mansell J; Hendrickson FR; Cohen L; Griffin TW
    J Neurooncol; 1986; 4(2):123-9. PubMed ID: 3537221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology Group.
    Laramore GE; Diener-West M; Griffin TW; Nelson JS; Griem ML; Thomas FJ; Hendrickson FR; Griffin BR; Myrianthopoulos LC; Saxton J
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1093-102. PubMed ID: 2838442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
    Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misonidazole combined with hyperfractionation in the management of malignant glioma.
    Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report.
    Shin KH; Urtasun RC; Fulton D; Geggie PH; Tanasichuk H; Thomas H; Muller PJ; Curry B; Mielke B; Johnson E
    Cancer; 1985 Aug; 56(4):758-60. PubMed ID: 3893680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
    Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
    Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of accelerated neutron therapy to control high grade astrocytomas.
    Saroja KR; Mansell J; Hendrickson FR; Cohen L; Lennox A
    Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1295-7. PubMed ID: 2557308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast neutrons in the treatment of grade IV astrocytomas.
    Breteau N; Schlienger M; Favre A; Lescrainier J; Touboul E; Stecken J; Heitzmann A
    Bull Cancer Radiother; 1996; 83 Suppl():135s-41s. PubMed ID: 8949766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial.
    Simpson JR; Perez CA; Phillips TL; Concannon JP; Carella RJ
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):303-8. PubMed ID: 7085386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast neutron therapy for malignant gliomas--results from NIRS study. National Institute of Radiological Sciences.
    Mizoe JE; Aoki Y; Morita S; Tsunemoto H
    Strahlenther Onkol; 1993 Apr; 169(4):222-7. PubMed ID: 8387697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).
    Urtasun RC; Cosmatos D; DelRowe J; Kinsella TJ; Lester S; Wasserman T; Fulton DS
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):207-14. PubMed ID: 8407393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
    Abratt RP; Sealy R; Tucker RD; Williams MA; Barnes DR; Johnson MB; Green JA; Cridland JS
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.